Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 22.


Barnett, Sarah E ORCID: 0000-0002-3470-7528, Kenyani, Jenna, Tripari, Martina, Butt, Zohra, Grosman, Rudi ORCID: 0000-0002-0233-7112, Querques, Francesca, Shaw, Liam, Silva, Luisa C, Goate, Zoe, Marciniak, Stefan J
et al (show 6 more authors) (2023) BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification. Molecular Cancer Research, 21 (5). pp. 411-427.


Sacco, Joseph J, Al-Akhrass, Hussein and Wilson, Cornelia M ORCID: 0000-0001-6584-6179
(2016) Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer. CURRENT PHARMACEUTICAL DESIGN, 22 (28). pp. 4374-4385.


Ye, Weiyu, Olsson-Brown, Anna, Watson, Robert A, Cheung, Vincent TF, Morgan, Robert D, Nassiri, Isar, Cooper, Rosalin, Taylor, Chelsea A, Akbani, Umair, Brain, Oliver
et al (show 7 more authors) (2021) Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. BRITISH JOURNAL OF CANCER, 124 (10). pp. 1661-1669.


Barnett, Sarah E, Herrmann, Anne, Shaw, Liam, Gash, Elisabeth N, Poptani, Harish ORCID: 0000-0002-0593-3235, Sacco, Joseph J and Coulson, Judy M ORCID: 0000-0003-2191-2001
(2022) The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation. CANCERS, 14 (23). 5836-.


Carvajal, Richard D, Butler, Marcus O, Shoushtari, Alexander N, Hassel, Jessica C, Ikeguchi, Alexandra, Hernandez-Aya, Leonel, Nathan, Paul, Hamid, Omid, Piulats, Josep M, Rioth, Matthew
et al (show 11 more authors) (2022) Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature Medicine, 28 (11). 2364-+.


Kenawy, Nihal, Kalirai, Helen ORCID: 0000-0002-4440-2576, Sacco, Joseph J, Lake, Sarah L, Heegaard, Steffen, Larsen, Ann-Cathrine, Finger, Paul T, Milman, Tatyana, Chin, Kimberly, Mosci, Carlo
et al (show 10 more authors) (2019) Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features and clinical outcome. Pigment cell & melanoma research, 32 (4). pp. 564-575.


Carter, Rachel J, Milani, Mateus, Butterworth, Michael, Alotibi, Ahoud, Harper, Nicholas, Yedida, Govindaraju, Greaves, Georgia, Al-Zebeeby, Aoula, Jorgensen, Andrea L ORCID: 0000-0002-6977-9337, Schache, Andrew G ORCID: 0000-0001-9466-6038
et al (show 7 more authors) (2019) Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck. Cell Death and Disease, 10 (12). 912-.


Hussain, Syed A, Palmeri, Daniel H, Syn, Wing-Kin, Sacco, Joseph J, Greensmith, Richard MD, Elmetwali, Taha, Aachi, Vijay, Lloyd, Bryony H, Jithesh, Puthen V, Arrand, John
et al (show 4 more authors) (2017) Gene expression profiling in bladder cancer identifies potential therapeutic targets. INTERNATIONAL JOURNAL OF ONCOLOGY, 50 (4). pp. 1147-1159.


Hussain, Syed A, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Syn, Wing Kin, Sacco, Joseph J, Lloyd, Bryony, Jithesh, Puthen, Arrand, John R, Barton, Darren, Ansari, Jawaher, Sibson, David R
et al (show 1 more authors) (2013) Gene expression profiling in bladder cancer to identify potential therapeutic targets. JOURNAL OF CLINICAL ONCOLOGY, 31 (15). pp. 1147-1159.


Brooker, Rachel C ORCID: 0000-0002-0668-6889, Antczak, Philipp ORCID: 0000-0001-9600-7757, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404, Risk, Janet M ORCID: 0000-0002-8770-7783, Sacco, Joseph J, Schache, Andrew G ORCID: 0000-0001-9466-6038 and Shaw, Richard J ORCID: 0000-0002-5157-4042
(2021) Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy. Radiotherapy and Oncology, 165. pp. 87-93. (In Press)


Cheung, Vincent Ting Fung, Gupta, Tarun, Olsson-Brown, Anna, Subramanian, Sreedhar ORCID: 0000-0002-6483-1730, Sasson, Sarah Christina, Heseltine, Jonathan, Fryer, Eve, Collantes, Elena, Sacco, Joseph J, Pirmohamed, Munir ORCID: 0000-0002-7534-7266
et al (show 9 more authors) (2020) Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way? BRITISH JOURNAL OF CANCER, 123 (2). pp. 207-215.


Eschweiler, Simon, Ramirez-Suastegui, Ciro, Li, Yingcong, King, Emma, Chudley, Lindsey, Thomas, Jaya, Wood, Oliver, von Witzleben, Adrian, Jeffrey, Danielle, McCann, Katy
et al (show 32 more authors) (2022) Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs. NATURE, 605 (7911). 741-+.


Bailey, Fiona P, Clarke, Kim, Kalirai, Helen ORCID: 0000-0002-4440-2576, Kenyani, Jenna, Shahidipour, Haleh, Falciani, Francesco ORCID: 0000-0003-1432-2871, Coulson, Judy M ORCID: 0000-0003-2191-2001, Sacco, Joseph J, Coupland, Sarah E ORCID: 0000-0002-1464-2069 and Eyers, Patrick A ORCID: 0000-0002-9220-2966
(2018) Kinome‐wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics. Pigment Cell and Melanoma Research, 31 (2). pp. 253-266.


Figueiredo, Carlos R, Kalirai, Helen ORCID: 0000-0002-4440-2576, Sacco, Joseph J, Azevedo, Ricardo A, Duckworth, Andrew, Slupsky, Joseph R ORCID: 0000-0002-7410-9004, Coulson, Judy M ORCID: 0000-0003-2191-2001 and Coupland, Sarah E ORCID: 0000-0002-1464-2069
(2020) Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. The Journal of Pathology, 250 (4). pp. 420-439.


Nathan, Paul, Hassel, Jessica C, Rutkowski, Piotr, Baurain, Jean-Francois, Butler, Marcus O, Schlaak, Max, Sullivan, Ryan J, Ochsenreither, Sebastian, Dummer, Reinhard, Kirkwood, John M
et al (show 18 more authors) (2021) Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. NEW ENGLAND JOURNAL OF MEDICINE, 385 (13). pp. 1196-1206.


Farquhar, Neil, Thornton, Sophie ORCID: 0000-0001-7693-7279, Coupland, Sarah E ORCID: 0000-0002-1464-2069, Coulson, Judy ORCID: 0000-0003-2191-2001, Sacco, Joseph J, Krishna, Yamini, Heimann, Heinrich, Taktak, Azzam, Cebulla, Colleen M, Abdel-Rahman, Mohamed H
et al (show 1 more authors) (2018) Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma. The Journal of Pathology: Clinical Research, 4 (1). pp. 26-38.


Carvajal, Richard D, Nathan, Paul, Sacco, Joseph J, Orloff, Marlana, Hernandez-Aya, Leonel F, Yang, Jessica, Luke, Jason J, Butler, Marcus O, Stanhope, Sarah, Collins, Laura
et al (show 4 more authors) (2022) Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of Clinical Oncology, 40 (17). 1939-+.


Sacco, Joseph J, Kalirai, Helen ORCID: 0000-0002-4440-2576, Kenyani, Jenna, Figueiredo, Carlos R, Coulson, Judy M ORCID: 0000-0003-2191-2001 and Coupland, Sarah E ORCID: 0000-0002-1464-2069
(2018) Recent breakthroughs in metastatic uveal melanoma: a cause for optimism? FUTURE ONCOLOGY, 14 (14). pp. 1335-1338.


Robinson, Helena, Eleuteri, Antonio ORCID: 0000-0003-0718-6672, Sacco, Joseph J, Hussain, Rumana ORCID: 0000-0001-8208-5009, Heimann, Heinrich, Taktak, Azzam FG, Damato, Bertil, Thompson, Alexander J, Allen, Thomas, Kalirai, Helen
et al (show 1 more authors) (2023) Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma. CANCERS, 15 (9). 2610-.


Sacco, Joseph J, Evans, Mererid, Harrington, Kevin J, Man, Stephen, Powell, Ned, Shaw, Richard J ORCID: 0000-0001-7027-8997 and Jones, Terry M
(2016) Systemic listeriosis following vaccination with the attenuated <i>Listeria monocytogenes</i> therapeutic vaccine, ADXS11-001. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 12 (4). pp. 1085-1086.


Malvehy, Josep, Samoylenko, Igor, Schadendorf, Dirk, Gutzmer, Ralf, Grob, Jean-Jacques, Sacco, Joseph J, Gorski, Kevin S, Anderson, Abraham, Pickett, Cheryl A, Liu, Kate
et al (show 1 more authors) (2021) Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9 (3). e001621-.


Visconti, Alessia, Rossi, Niccolo, Deris, Helena, Lee, Karla A, Hanic, Maja, Trbojevic-Akmacic, Irena, Thomas, Andrew M, Bolte, Laura A, Bjork, Johannes R, Hooiveld-Noeken, Jahlisa S
et al (show 17 more authors) (2023) Total serum <i>N-</i>glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma. BMC CANCER, 23 (1). 166-.

This list was generated on Fri Feb 9 22:37:27 2024 GMT.